Trials / Completed
CompletedNCT00892554
The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
The Impact of Docosahexaenoic Acid on Neuropsychological Status in Females With Phenylketonuria
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Emory University · Academic / Other
- Sex
- Female
- Age
- 12 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if taking supplemental DHA improves measures of processing speed and executive function in teen and adult women with PKU.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Docosahexaenoic Acid | Capsules providing 10 mg DHA/kg body weight/day taken once daily |
| DIETARY_SUPPLEMENT | Corn/soy oil | Capsules taken once daily |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2009-05-04
- Last updated
- 2015-12-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00892554. Inclusion in this directory is not an endorsement.